• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail

Varivax Varicella Virus Vaccine Live

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)

 

March 2014

Summary View

ADVERSE REACTIONS

Postmarketing Experience
  • necrotizing retinitis (in immunocompromised individuals)